Eric Karas

Chief Commercial Officer, Silverback Therapeutics.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jun 12, 2026Sold 25,000 shares at $10.00 of Silverback Therapeutics²
Jun 12, 2026Exercised options 25,000 shares at $1.50 of Silverback Therapeutics²
Jul 1, 2025Sold 15,000 shares at $16.99 of Silverback Therapeutics³
Jul 1, 2025Exercised options 15,000 shares at $1.50 of Silverback Therapeutics³
Jun 18, 2025Sold 15,000 shares at $16.00 of Silverback Therapeutics⁴
Jun 18, 2025Exercised options 15,000 shares at $1.50 of Silverback Therapeutics⁴
Mar 20, 2025Sold 10,000 shares at $14.00 of Silverback Therapeutics⁵
Mar 20, 2025Exercised options 10,000 shares at $1.50 of Silverback Therapeutics⁵
Dec 4, 2024Sold 6,283 shares at $14.00 of Silverback Therapeutics⁶
Dec 4, 2024Exercised options 6,283 shares at $1.50 of Silverback Therapeutics⁶
Dec 2, 2024Sold 3,717 shares at $14.11 of Silverback Therapeutics⁶
Dec 2, 2024Exercised options 3,717 shares at $1.50 of Silverback Therapeutics⁶
Sep 18, 2024Sold 10,000 shares at $14.00 of Silverback Therapeutics⁷
Sep 18, 2024Exercised options 10,000 shares at $1.50 of Silverback Therapeutics⁷
Aug 19, 2024Sold 10,000 shares at $14.00 of Silverback Therapeutics⁸
Aug 19, 2024Exercised options 10,000 shares at $1.50 of Silverback Therapeutics⁸

The numbers on this page point here. Each one links to the record it came from.